UNSPSC 51372308: Ocfentanil

This classification denotes an opioid receptor agonist with the molecular formula C22H27FN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MX52WBC8EV, chemically known as acetamide, n-(2-fluorophenyl)-2-methoxy-n-(1-(2-phenylethyl)-4-piperidinyl)- but generally known as ocfentanil, which bears US NIH Compound Identifier 60575. European Medicines Agency schedules Ocfentanil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09396MIG.

UNSPSC 51372308 Ocfentanil (Commodity) does not match the actual work state and local governments are procuring under this code. The single recent opportunity in the source—Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems—concerns naloxone procurement and opioid-response equipment, not ocfentanil. The mismatch suggests either a miscoding of the Seminole County solicitation or minimal recent activity tagged to the ocfentanil commodity code itself. State and local procurement under this code shows insufficient recent activity to characterize scope, issuing-body patterns, or geographic concentration with confidence.

Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023. Beyond this single Seminole County sourcing event, the source contains no other recent state or local opportunities coded to ocfentanil, making it impossible to identify repeat buyers, broader geographic activity, or representative procurement patterns.